Intelligence desk 12 languages Signal over noise

Irish Health

Tracking health policy, system performance, and medical innovation for Irish patients, clinicians, and public health professionals.

From Sláintecare timelines to HIQA inspection results and prescribing data from the Primary Care Reimbursement Service — daily briefings on the policies, research, and service metrics that matter in Ireland.

About us

Why this desk matters

Curated relevance

Track policy in real time — automatic digests of Oireachtas health committee hearings, Department of Health white papers, and IMO position statements, clustered by topic so you never miss a regulatory shift.

Pattern-aware briefings

Medical breakthroughs with Irish impact — clinical trial updates from the HRB and CRF, FDA/EMA approvals, and NICE guidelines relevant to Irish prescribing, with patient-relevant context in plain language.

Cross-language clarity

Service delivery metrics at a glance — weekly aggregation of hospital waiting lists, ED overcrowding figures, CHO budget data, and HIQA nursing home inspection results, all in one place.

Latest Spotlight

Open archive

Latest briefing

Open archive
AI-designed vaccine and ERAP1 inhibitor show early promise; HIQA updates disability standards

2026-06-03 - 2026-06-09 · 7 days

This week's developments spanned biomedical breakthroughs and Irish regulatory updates. The first human trial of an AI-designed coronavirus vaccine antigen, reported by Cambridge researchers, induced modest immune responses in 39 participants, with plans for a larger trial. The antigen targets all coronaviruses, includ

  • AI-designed coronavirus vaccine antigen completed first human trial; larger efficacy trial planned.
  • ERAP1 inhibitor GRWD5769 plus cemiplimab shrank tumors in 26 of 83 patients with advanced cancers.

Recent posts

View all